SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Shares
Shares outstanding: 71,858,757
Number of holders: 13
Total 13F shares, excl. options: 654,395
Shares change: +338,809
Total reported value, excl. options: $4,040,321
Value change: +$1,998,321
Number of buys: 12
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2023

13 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2023.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 654,395 shares of 71,858,757 outstanding shares and own 0.91% of the company stock.
Largest 10 shareholders include Neumann Advisory Hong Kong Ltd (315,586 shares), STATE STREET CORP (160,875 shares), Yorktown Management & Research Co Inc (74,893 shares), Skandinaviska Enskilda Banken AB (publ) (40,000 shares), GEODE CAPITAL MANAGEMENT, LLC (27,717 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,430 shares), UBS Group AG (9,095 shares), MORGAN STANLEY (4,566 shares), JPMORGAN CHASE & CO (3,000 shares), and WELLS FARGO & COMPANY/MN (1,661 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.